Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORL-1G in Glycogen Storage Disease Type 14
NCT03404856Phase 2Unknown
- Sponsor
- Orpha Labs
- Start
- Oct 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of D-galactose in Glycogen Storage Disease Type XIV, sponsored by Orpha Labs. Status: unknown.
02
Drugs
D-galactose
03
Conditions
Glycogen Storage Disease Type XIV
Beyond the preview
Go deeper on NCT03404856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03404856.